My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Medicina
Print version ISSN 0034-7523On-line version ISSN 1561-302X
Abstract
MORALES SANCHEZ, Lisvenia et al. Survival rate of patients presenting with bronchogenic carcinoma from "Hermanos Ameijeiras" Clinical Surgical Hospital, 1997-2002. Rev cubana med [online]. 2009, vol.48, n.3, pp.15-27. ISSN 0034-7523.
Survival from 201 patients was studied, which were diagnosed with bronchogenic carcinoma (155 with non-small cell carcinoma and 46 with small cell carcinoma) different modalities of specific oncotherapy from 1997 to 2002. Sample was described and the survival was analyzed by Kaplan Meier method according to variables including age, histological lineage, clinical status and treatment used. We noted that 5-years global survival was of 18,5% for non-small cells lung carcinoma. Main predisposing factors of disease were the probability of surgical treatment. Use of chemotherapy as surgery adjuvant regime improves survival of patients operated on. 5-years mean survival achieved in patients presenting with in small cells non-differentiated carcinoma was of 4,5%.
Keywords : Survival; lung cancer; chemotherapy; staging; radiotherapy; remission.